Valentina Matteo

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Clinical phenotype and laboratory markers in patients affected by haploinsufficiency of A20 (HA20): a case series from two Italian centres.

Clinical phenotype and laboratory markers in patients affected by haploinsufficiency of A20 (HA20): a case series from two Italian centres.

Journal: RMD open

Published: January 25, 2026

Interleukin-18 Levels Are Associated With Disease Course in Patients With Still Disease Treated With Interleukin-1 Inhibitors.

Interleukin-18 Levels Are Associated With Disease Course in Patients With Still Disease Treated With Interleukin-1 Inhibitors.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: August 11, 2025

Interleukin-18 levels are associated with disease course in patients with Still's disease treated with IL-1 inhibitors.

Interleukin-18 levels are associated with disease course in patients with Still's disease treated with IL-1 inhibitors.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: August 11, 2025

SIGLEC-1 expression on monocytes as a diagnostic biomarker in pediatric type I interferon-mediated diseases.

SIGLEC-1 expression on monocytes as a diagnostic biomarker in pediatric type I interferon-mediated diseases.

Journal: The Journal of allergy and clinical immunology

Published: July 31, 2025

Genome-wide DNA methylation analysis identifies kidney epigenetic dysregulation in a cystinosis mouse model.

Genome-wide DNA methylation analysis identifies kidney epigenetic dysregulation in a cystinosis mouse model.

Journal: Frontiers in cell and developmental biology

Published: June 05, 2025

Traditional laboratory parameters and IFNγ-related biomarkers in the diagnosis and management of MAS.

Traditional laboratory parameters and IFNγ-related biomarkers in the diagnosis and management of MAS.

Journal: Seminars in arthritis and rheumatism

Published: April 09, 2025

Correction to: Anifrolumab in Monogenic Lupus caused by TREX1 Mutation.

Correction to: Anifrolumab in Monogenic Lupus caused by TREX1 Mutation.

Journal: Journal of clinical immunology

Published: February 03, 2025

Anifrolumab in Monogenic Lupus caused by TREX1 Mutation.

Anifrolumab in Monogenic Lupus caused by TREX1 Mutation.

Journal: Journal of clinical immunology

Published: November 07, 2024

Innate Lymphoid Cell Phenotypic and Functional Alterations in Patients With Systemic Juvenile Idiopathic Arthritis.

Innate Lymphoid Cell Phenotypic and Functional Alterations in Patients With Systemic Juvenile Idiopathic Arthritis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: November 05, 2024

Different patterns of longitudinal changes in antinuclear antibodies titers in children with systemic lupus erythematosus and Sjögren's syndrome.

Different patterns of longitudinal changes in antinuclear antibodies titers in children with systemic lupus erythematosus and Sjögren's syndrome.

Journal: Lupus

Published: November 04, 2024

Long-term effects of luteolin in a mouse model of nephropathic cystinosis.

Long-term effects of luteolin in a mouse model of nephropathic cystinosis.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 04, 2024

Nlrp2 deletion ameliorates kidney damage in a mouse model of cystinosis.

Nlrp2 deletion ameliorates kidney damage in a mouse model of cystinosis.

Journal: Frontiers in immunology

Published: January 19, 2024

Showing 1-12 of 17

Last Updated: 09/26/2026